LEADER 01191nam--2200385---450-
001 990003571000203316
005 20111006114439.0
010   $a978-3-642-17968-6
035   $a000357100
035   $aUSA01000357100
035   $a(ALEPH)000357100USA01
035   $a000357100
100   $a20110929d2011----km-y0itay50------ba
101 0 $aeng
102   $aDE
105   $aa---||||001yy
200 1 $aPhosphodiesterases as drug targets$fSharron H. Francis, Marco Conti, Miles D. Houslay, editors
210   $aBerlin$cSpringer$d2011
215   $aXVII, 519 p.$cill.$d24 cm
225 2 $aHandbook of experimental pharmacology$v204
410  0$12001$aHandbook of experimental pharmacology$v204
610   $aFosfodiesterasi$2BNCF
676   $a572.76
702  1$aFRANCIS,$bSharron H.
702  1$aCONTI,$bMarco
702  1$aHOUSLAY,$bMiles D.
801  0$aIT$bsalbc$gISBD
912   $a990003571000203316
951   $a572.76 PHO 1$b5503 Farm.$c572.76$d00299577
959   $aBK
969   $aFAR
979   $aIANNONE$b90$c20110929$lUSA01$h0915
979   $aIANNONE$b90$c20111006$lUSA01$h1144
996   $aPhosphodiesterases as drug targets$91115290
997   $aUNISA